What is the appropriate dose of Miralax (polyethylene glycol 3350) for a 2.5-year-old child?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 17, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Miralax Dosing for a 2.5-Year-Old Child

For a 2.5-year-old child with constipation, start with 0.5-0.8 g/kg/day of polyethylene glycol 3350 (PEG 3350/Miralax), which typically translates to approximately 1-2 level tablespoons (10-20 grams) daily, mixed in 4-8 ounces of liquid.

Weight-Based Dosing Approach

The most evidence-supported approach uses weight-based dosing rather than age alone:

  • Starting dose: 0.5-0.8 g/kg/day 1
  • Effective maintenance range: 0.27-1.42 g/kg/day, with mean effective dose of 0.84 g/kg/day 1
  • Maximum studied dose: Up to 1.5 g/kg/day for disimpaction 2

For a typical 2.5-year-old weighing 12-14 kg:

  • Initial dose would be 6-11 grams daily (starting conservatively)
  • Can titrate up to 10-17 grams daily based on response
  • Adjust every 2-3 days to achieve 1-2 soft, painless stools daily

Practical Measurement Guidance

Since household measuring devices are commonly used 3:

  • 1 level tablespoon ≈ 10 grams of PEG 3350
  • 1 level teaspoon ≈ 3.3 grams of PEG 3350
  • The manufacturer's capful = 17 grams (adult dose)

Use leveled measurements with a dedicated measuring device to improve consistency 3. Unleveled or "heaping" measurements create significant variability and should be avoided.

Administration Details

  • Mix powder completely in any beverage (4-8 oz for pediatric doses) 4
  • Give once daily, preferably at the same time
  • Can be given with or without food, though with meals may reduce GI side effects
  • The powder is unflavored and grit-free when properly dissolved 4

Safety Profile for Young Children

PEG 3350 has been extensively studied in children under 2 years 5:

  • No serious adverse events reported in systematic reviews of children <24 months
  • Common transient side effects: diarrhea (13%), bloating (18%), abdominal cramping (5%), nausea/vomiting (5%) 2
  • These effects are dose-dependent and typically resolve with dose adjustment
  • No clinically significant electrolyte abnormalities noted in pediatric studies 1, 2

Titration Strategy

  1. Start at lower end of dosing range (0.5 g/kg/day or 1 tablespoon)
  2. Assess response after 2-3 days: goal is 1-2 soft, painless stools daily
  3. Increase by 0.2-0.3 g/kg (or ½ tablespoon) every 2-3 days if inadequate response
  4. Decrease dose if diarrhea or excessive stooling occurs
  5. Continue maintenance therapy for several months to prevent recurrence 6

Important Caveats

  • Avoid in renal insufficiency (though this is rare in toddlers, it's worth noting from adult guidelines 7)
  • If fecal impaction is present, higher disimpaction doses (1-1.5 g/kg/day for 3 days) may be needed before starting maintenance 2
  • PEG 3350 is FDA-approved only for "occasional constipation" in adults, but extensive pediatric evidence supports its use for chronic functional constipation in children of all ages 5, 1, 6
  • One case report exists of potential contamination with ethylene glycol in generic formulations 8, though this is extremely rare; use reputable brands

Why PEG 3350 Over Alternatives

For this age group, PEG 3350 is preferred over alternatives like magnesium hydroxide because:

  • Equal efficacy but better palatability and acceptance in young children 9
  • More consistent evidence base for children under 4 years 5
  • Osmotic mechanism is gentle and physiologic
  • Can be mixed in any beverage, improving compliance

The evidence strongly supports PEG 3350 as first-line therapy for functional constipation in toddlers, with a well-established safety profile and flexible dosing that can be individualized based on clinical response 5, 1, 6.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.